Trial Profile
Multicenter study on the antidepressant effect of istradefylline for Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2020
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 29 Jan 2019 Status changed from recruiting to completed.
- 13 May 2016 New trial record